Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000212641 | SCV000149275 | uncertain significance | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21437237, 36091175, 25318351) |
Ambry Genetics | RCV000115366 | SCV000186100 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-05-27 | criteria provided, single submitter | clinical testing | The p.P343L variant (also known as c.1028C>T), located in coding exon 4 of the MSH6 gene, results from a C to T substitution at nucleotide position 1028. The proline at codon 343 is replaced by leucine, an amino acid with some similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000469621 | SCV000551201 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-12-10 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000212641 | SCV002046242 | uncertain significance | not provided | 2020-09-25 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004566998 | SCV005055021 | uncertain significance | Endometrial carcinoma | 2023-11-29 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004806063 | SCV005429249 | uncertain significance | Lynch syndrome | 2024-03-24 | criteria provided, single submitter | clinical testing | This missense variant replaces proline with leucine at codon 343 of the MSH6 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual who underwent genetic hereditary cancer testing (PMID: 25318351). This variant has also been reported in an individual affected with malignant seminoma (PMID: 36091175). This variant has been identified in 2/282698 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |